T1	Participants 55 107	bestatin of acute nonlymphocytic leukemia in adults.
T2	Participants 409 451	adult acute nonlymphocytic leukemia (ANLL)
T3	Participants 609 655	101 eligible cases (bestatin: 48, control: 53)
